✦ LIBER ✦
Mode of chemotherapy does not affect complications with an implantable venous access device
✍ Scribed by Danielle F. Brown; Michael J. Muirhead; Patrick M. Travis; Sharon R. Vire; JoAnn Weller; Martin Hauer-Jensen
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 101 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
RESULTS.
Twenty-seven patients experienced 1 complication each: 17 episodes of 3 Department of Nursing, John L. McClellan Medevice-related sepsis, cellulitis, or fever of unknown origin; 8 episodes of thrombomorial Veterans Administration Medical Center, sis or catheter occlusion; 1 episode of drug extravasation; and 1 mechanical failure. Little Rock, Arkansas. Patient age, frequency of port accession, mode of chemotherapy delivery, tumor type, and neutropenia were evaluated as risk factors, but none was statistically